Engerix-B (hepatitis B vaccine [recombinant]) dosing schedule and details. Medically reviewed by Stan Saji, PharmD, MBA, RPh — Written by Kaylea Swearingen, PharmD on April 2, 2025.

Recombinant hepatitis B vaccines are of the A2 genotype; one of ten known genotypes whose distribution varies globally. Reports of rare HBV infections in blood donors with an imbalance of non-A2 ...

The Company launched its first commercial product, HEPLISAV-B® [Hepatitis B Vaccine (Recombinant), Adjuvanted], in February 2018, following U.S. FDA approval for prevention of infection caused by ...

VBI Vaccines announced that the FDA has approved the company’s recombinant trivalent hepatitis B vaccine, PreHevbrio, for adults aged 18 years or older. According to VBI Vaccines, PreHevbrio ...

HHS Secretary Robert F. Kennedy Jr. and the CDC vaccine panel have been casting doubt on the hepatitis B shot and the ...

The global Hepatitis B Vaccine (Recombinant) market is expected to reach US$ 9.5 billion by 2030, with an annual growth rate of more than 5.6%.Wilmington, Delaware, Nov. 09, 2023 (GLOBE NEWSWIRE ...

A recent drug shortage of recombinant hepatitis B vaccine (Recombivax HB, Merck) was reported, and it affects all available product strengths, including adult and pediatric/adolescent dosages (see ...

When comparing the seroprotection rate at week 28 for both vaccines among adults with type 2 diabetes aged 18 to 70 years, Heplisav-B demonstrated a higher rate vs Engerix-B (90.0% vs 65.1%).

Hepatitis B is a viral infection of the liver that is most commonly transmitted from mother to child during birth and delivery in early childhood, as well as through contact with blood or other body ...

BERKELEY, Calif. — An experimental vaccine for hepatitis B made by Dynavax Technologies appears to work better in patients with diabetes than current treatments, the company said.

The chair of Robert F. Kennedy Jr.'s newly constituted vaccine advisory committee announced in his first meeting that the ...

Hepatitis B Vaccine Effectiveness in the Face of Global HBV Genotype Diversity. ... Plasma-derived HBV vaccines were used until 1991 and recombinant vaccines thereafter.